Timo Soeterik

76 CHAPTER 4 SUPPLEMENTARY FIGURE S2. Impact of mpMRI stage ≥T3a (EPE) on biochemical recurrence-free survival per risk group A. Low-risk (N = 36) B. Intermediate-risk (N = 158) Log-rank test: N/A (no events) Log-rank test: p = 0.099 C. High-risk (localized) (N = 74) D. High-risk (locally advanced) (N = 25) Log-rank test: p = 0.83 Log-rank test: p = 0.23